10 October 2019
("Volex" or the "Company")
Volex plc, the global supplier of complex assemblies for performance-critical applications and power products, announces that it was notified today that on 9 October 2019 NR Holdings Ltd purchased 100,000 ordinary shares of 25 pence in the Company at a price of 86.825 pence per share. Following this purchase, Nat Rothschild, Executive Chairman of the Company, a beneficiary of NR Holdings Ltd, will hold 36,276,078 ordinary shares in total, representing 24.21% of the ordinary issued share capital of the Company.
This announcement is made in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
For further information please contact:
Volex plc +44 7909 995 887
Nat Rothschild, Executive Chairman
Daren Morris, Chief Financial Officer and Company Secretary
N+1 Singer - Nominated Adviser & Joint Broker +44 20 7496 3000
Whitman Howard - Joint Broker +44 20 7659 1234
NOTIFICATION OF TRANSACTIONS BY DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED
Details of the Director / person discharging managerial responsibilities / person closely associated
Nat Rothschild (as a beneficiary of NR Holdings Ltd)
Reason for the notification
Initial notification / Amendment
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Ordinary 25 pence Shares
Nature of the transactions
Price(s) and volume(s)
100,000 Ordinary 25 pence Shares at £0.86825 per Share.
- Aggregated volume
See 4 c) above
Date of the transactions
09 October 2019
Place of the transactions
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.